1.Experimental research on antagonistic effect of heme oxygenase-1 on acute mercury chloride induced renal impairment.
Ying ZHANG ; Wei-cheng ZENG ; Rong CHEN ; Shun-rong WANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2006;24(5):289-290
Animals
;
Heme Oxygenase-1
;
biosynthesis
;
Kidney
;
drug effects
;
metabolism
;
Male
;
Mercuric Chloride
;
toxicity
;
Oxidative Stress
;
drug effects
;
Random Allocation
;
Rats
;
Rats, Wistar
2.Some leukocyte differentiation antigens express in side population cells in leukemia K562 cell line
Ruihua FAN ; Dianxuan GUO ; Tiecheng ZHANG ; Shun YUE ; Mingde HUANG ; Rong YAO
Chinese Journal of Tissue Engineering Research 2013;(49):8596-8601
BACKGROUND:To study the phenotypes of side population cells in leukemia is important for understanding the heterogeneity and origin of tumor cells, molecular markers and targeted therapy.
OBJECTIVE:To identify whether the human chronic myeloid leukemia cellline-K562 contains side population cells or not, and to further observe the differences in expressions of leukocyte differentiation antigens from side population cellsubset and non-side population cells subset.
METHODS:Flow cytometry was used to detect whether there were side population cells in the K562 celllines. Then, the expression of CD34+, CD34+CD38-, CD34+CD38+, HLA-DR+cells in the side population subsets and non-side population subsets.
RESULTS AND CONCLUSION:Flow cytometry results showed that the K562 cellline contained side population cells, and the proportion of side population cells was much lower. The side population cells accounted for (2.7±0.5)%of viable cells in K562. The expressions of CD34+cells and CD34+CD38-cells in the side population subset were significantly higher than those in the non-side population subsets. The expressions of CD34+CD38+cells and HLA-DR+cells in the side population subset and non-side population subset did not have a significant difference. Heterogeneity was found in the differentiation antigen expression between the side population subset and non-side population subset.
3.Not Available.
Lu shun ZHANG ; Shao qi YANG ; Zhi rong LIU ; Wen chao JIN ; Yue HE
Journal of Forensic Medicine 2021;37(5):708-710
4.Urothelial-type mucinous adenocarcinoma of the prostate: A case report and review of the literature.
Yong-shun GUO ; Su-mei GAO ; Ming-rong ZHANG ; Ju-min ZHANG ; Yun-jiang ZANG ; Hong-kai LU
National Journal of Andrology 2016;22(3):241-245
OBJECTIVETo investigate the clinical manifestations, pathological characteristics, and treatments of urothelial-type mucinous adenocarcinoma of the prostate (UMAP).
METHODSWe reported a case of UMAP, reviewed relevant literature, and analyzed the clinicopaothological features, diagnosis, treatment, and prognosis of the disease.
RESULTSThe patient was a 60-year-old male and underwent transurethral resection of the prostate for dysuria. Postoperative pathology indicated mucinous adenocarcinoma and sigmoidoscopy revealed no primary colon cancer. Immunohistochemical staining showed the negative expressions of PSA and P504s and positive expressions of CK7, CK34 β E12, CK20, and CDX2. Thus UMAP was confirmed and treated by intensity-modulated radiotherapy. Then the patient was followed up for 30 months, which showed desirable therapeutic result, with neither local progression nor distant metastasis.
CONCLUSIONUMAP has a bad prognosis and its diagnosis depends on pathological and immunohistocchemical examinations. It responds well to radical prostatectomy but is not sensitive to endocrine therapy. Radiotherapy can be considered for those who are not fit to receive radical prostatectomy.
Adenocarcinoma, Mucinous ; metabolism ; pathology ; therapy ; Humans ; Keratins ; metabolism ; Male ; Middle Aged ; Neoplasm Proteins ; metabolism ; Prognosis ; Prostatectomy ; Prostatic Neoplasms ; metabolism ; pathology ; therapy ; Racemases and Epimerases ; metabolism
5.Study on the compatibility of composite herbal medicines of the Zishen pill.
Rong-hua DAI ; Yuan-yuan ZHANG ; Kai-shun BI
China Journal of Chinese Materia Medica 2004;29(9):897-899
OBJECTIVETo study the compatibility of composite herbal medicines of the Zishen pill.
METHOD50% ethanol extract test solution of the different combinations of composite herbal medicines of the Zishen pill were prepared. Pharmacologic experiments, such as anti-inflammatory, carbon particle clearance of RES were carried out with the solutions, and the corresponding pharmacological data were obtained. Variance analysis, canonical correlation and stepwise regression analysis were applied to interrelate the amount of each drug and the pharmacological data.
RESULTThe results confirmed that Huangbo and Zhimu were the basis, while Rougui was the corrigent, which was conformed to the theory of TCM.
CONCLUSIONThis study provides a significant try for studying the compatibility of composite herbal medicines.
Anemarrhena ; chemistry ; Animals ; Anti-Inflammatory Agents, Non-Steroidal ; pharmacology ; Carbon ; pharmacokinetics ; Cinnamomum ; chemistry ; Drug Combinations ; Drug Interactions ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Ear ; pathology ; Ear Diseases ; pathology ; Edema ; pathology ; Male ; Metabolic Clearance Rate ; drug effects ; Mice ; Phellodendron ; chemistry ; Plants, Medicinal ; chemistry
6.Study on extraction process of polysaccharide from Sargassum fusiforme by enzymatic treatment.
Hua-fang ZHANG ; Jing-shun JIN ; Rong-mei TAN ; Cheng SHEN
China Journal of Chinese Materia Medica 2006;31(22):1860-1862
OBJECTIVETo investigate the optimal extraction process of polysaccharides from S. fusiforme by enzymatic treatment.
METHODThe optimum extraction conditions were obtained by the experiment with the orthogonal design. The content of polysaccharides of S. fusiforme was determined by spectraphotometry.
RESULTThe amount of enzyme and temperature significantly affected total polysaccharides of S. fusiforme.
CONCLUSIONThe optimum extraction conditions include the addition of 1. 2 x 10 (4) U x 100 g(-1) enzyme into water at pH 4. 5, and the subsequent treatment for 10 min while the temperature is maintained at 45 degrees C.
Cellulase ; metabolism ; Hydrogen-Ion Concentration ; Polysaccharides ; analysis ; isolation & purification ; metabolism ; Sargassum ; chemistry ; Technology, Pharmaceutical ; methods ; Temperature
7.Evaluation of effective doses of hepatitis B immunoglobulin to eliminate hepatitis B surface antigen from infected neonates.
Ping ZHANG ; Wei LU ; Shun-tian LI ; Wei YOU ; Yu-rong ZHANG ; Jing CHEN
Chinese Journal of Hepatology 2012;20(1):17-19
OBJECTIVETo determine the effective dose of hepatitis B immunoglobulin (HBIG) for clearing maternally-transmitted hepatitis B virus (HBV) from a newborn.
METHODSFull-term neonates born to HBV-infected mothers were tested for hepatitis B surface antigen (HBsAg) and HBV DNA in venous blood, Individuals with positive results within two hours after birth were selected for study, and divided among two treatment groups: research group receiving HBIG continually adjusted to quantitative levels of neonatal HBsAg and HBV DNA levels; control group receiving standard HBIG 200IU dose. All neonates were also treated with 10 micrograms of recombinant vaccine. The decreases in HBsAg and HBV DNA over 12 months were comparatively analyzed between the two treatment groups.
RESULTSThe two treatment groups (HBIG adjusted vs. standard) were statistically similar in Apgar score (9.38+/-0.49 vs. 9.37+/-0.48), neonate body weight (3458.67+/-374.93 vs. 3558.61+/-322.85 g), maternal age (26.33+/-3.63 vs. 25.33+/-3.03), and initial HBsAg and HBV DNA levels (rank sum test Z = 1.381, and Z = 0.700, respectively) (all, P more than 0.05). Successful clearance of HBV infection within 12 months was achieved in significantly more neonates in the HBIG adjusted therapy group than in the standard therapy group (82.8% vs. 57.4%; x2 = 9.696, P less than 0.05).
CONCLUSIONAdjusting the neonatal HBIG dose according to HBsAg and HBV DNA levels can improve the success rate of clearing maternally-transmitted HBV.
DNA, Viral ; Dose-Response Relationship, Immunologic ; Female ; Hepatitis B ; prevention & control ; therapy ; Hepatitis B Surface Antigens ; blood ; immunology ; Hepatitis B virus ; genetics ; immunology ; Humans ; Immunoglobulins ; administration & dosage ; therapeutic use ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; prevention & control
8.Expression and significance of P311 and ITGB4BP in non-small cell lung cancer.
Chun-lan TANG ; Shun-zong YUAN ; He-ping YANG ; Qing-liang WANG ; Rong ZHANG
Chinese Journal of Oncology 2010;32(7):526-528
OBJECTIVEThe aim of this study was to investigate the expression and significance of P311 and ITGB4BP in non-small cell lung cancer (NSCLC).
METHODSTissue microarrays were prepared from 80 NSCLC specimens and examined by immunohistochemistry.
RESULTSThe positive rates of P311 and ITGB4BP expression were 77.5% (62/80) and 82.5% (66/80), respectively. The double positive expression rate was 73.8% (59/80). The consistency rate was 87.5%, and there was a significant consistency between P311 and ITGB4BP expressions (Kappa = 0.611, P < 0.001).
CONCLUSIONThere may be a new signaling pathway P311-ITGB4BP in NSCLC, and it may regulate the lung cancer cell migration.
Adenocarcinoma ; metabolism ; Carcinoma, Non-Small-Cell Lung ; metabolism ; Carcinoma, Squamous Cell ; metabolism ; Eukaryotic Initiation Factors ; metabolism ; Humans ; Immunohistochemistry ; Lung Neoplasms ; metabolism ; Nerve Tissue Proteins ; metabolism ; Oncogene Proteins ; metabolism ; Paraffin Embedding ; Signal Transduction ; Tissue Array Analysis
9.Clinical analysis on 40 patients with chronic lymphocytic leukemia.
Zhen-Shu XU ; Jin-Yan ZHANG ; Rong ZHAN ; Zhi-Hong ZHENG ; Shun-Quan WU ; Zhi-Zhe CHEN
Journal of Experimental Hematology 2012;20(3):583-586
This study was aimed to analyze the clinical and laboratorial characteristics of patients with chronic lymphocytic leukemia (CLL), as well as their relationship with outcomes of patients. The clinical and laboratorial data of 40 CLL patients admitted from 2004 to 2010 in our hospital were analyzed retrospectively. The results indicated that the most of CLL attacked the elderly male patients with median age 66 (from 42 to 80). Flow cytometric analysis showed that 25 cases were positive for typical immunophenotype of CLL. On the other hand, all the patients clearly expressed CD19 and CD5, 7 cases (17.5%) and 14 cases (35%) were positive for the expression of CD38 and Zap70 respectively. 8 cases harbored a mutated immunoglobulin heavy-chain (VH) gene, among them 4 cases belong to VH3 family. Interphase FISH analysis showed that P53 deletion, RB1 deletion, trisomy 12 and normal chromosome were detected in 6, 3, 1, and 5 cases, respectively. The median PFS in 31 patients received treatment of fludarabine based chemotherapy was 48 months (95%CI: 39 - 57 months), among them 27 cases (87.1%) achieved CR + PR. While PFS was 14 months (95%CI: 10 - 18 months, P < 0.001) in 9 patients received other treatment regimen, out of them only 3 cases (33.3%) achieved CR + PR. Patients with normal level of serum β2-microglobulin at diagnosis showed significantly higher overall survival (78%, 95%CI: 69% - 87%) in 36 months than those with abnormal level of serum β2-microglobulin (47%, 95%CI: 35% - 59%, P = 0.004). Significant difference in the rate of CR + PR was noted in the Zap70 positive group (50%) and in negative group (88.5%, P = 0.006). All of 8 patients with IgVH mutation displayed CR after treatment, while 4 cases (66.7%) archived CR among 6 patients without IgVH mutation. It is concluded that CLL is characterized by high heterogeneity in both clinical features and molecular markers, which are associated with prediction of outcomes for patients. The treatment with fludarabine-based chemotherapy results in a major benefit and long survival for patients with CLL.
ADP-ribosyl Cyclase 1
;
metabolism
;
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Flow Cytometry
;
Humans
;
Immunoglobulin Variable Region
;
genetics
;
Leukemia, Lymphocytic, Chronic, B-Cell
;
genetics
;
metabolism
;
Male
;
Middle Aged
;
Mutation
;
Retrospective Studies
;
ZAP-70 Protein-Tyrosine Kinase
;
metabolism
10.Clinical observation on point-through-point acupuncture for treatment of cerebellar ataxia after apoplexy.
Shun WANG ; Yu-ying CAI ; Bing-cheng HU ; Jin-rong LU ; Zhong-ren SUN ; Ya-li ZHANG
Chinese Acupuncture & Moxibustion 2006;26(1):75-77
OBJECTIVETo observe therapeutic effect of point-through-point acupuncture on cerebellar ataxia after apoplexy and evaluate the safety.
METHODSRandom, parallel control, single blind and multicentral study method was used and 224 cases from 4 hospitals were divided equally into a treatment group and a control group, 112 cases in each group. The treatment group were treated with point-through-point acupuncture and the control group with general needling method. Their symptoms and signs, and the effect on transcranial Doppler's method (TCD) were investigated.
RESULTSThe total effective rate was 93.3% in the treatment group which was better than 77.4% in the control group, with a significant difference between the two groups (P < 0.01), and the point-through-point acupuncture could significantly improve TCD of basilar artery, vertebral artery and posterior inferior cerebellar artery (Vs, Vm, Vd, PI, RI), superior to the control group.
CONCLUSIONThe point-through-point acupuncture has obvious therapeutic effect on cerebellar ataxia after apoplexy and good safety.
Acupuncture Points ; Acupuncture Therapy ; Cerebellar Ataxia ; Humans ; Single-Blind Method ; Stroke ; therapy